BIOBIJOU Co.,Ltd. (KOSDAQ:489460)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,570
-60 (-0.36%)
Last updated: Sep 18, 2025, 1:27 PM KST

BIOBIJOU Statistics

Total Valuation

BIOBIJOU has a market cap or net worth of KRW 245.83 billion. The enterprise value is 211.86 billion.

Market Cap245.83B
Enterprise Value 211.86B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BIOBIJOU has 15.04 million shares outstanding.

Current Share Class 15.04M
Shares Outstanding 15.04M
Shares Change (YoY) n/a
Shares Change (QoQ) +6.34%
Owned by Insiders (%) 8.97%
Owned by Institutions (%) 4.61%
Float 5.11M

Valuation Ratios

The trailing PE ratio is 25.84.

PE Ratio 25.84
Forward PE n/a
PS Ratio 7.23
PB Ratio 4.02
P/TBV Ratio 4.03
P/FCF Ratio 41.73
P/OCF Ratio 40.32
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.71, with an EV/FCF ratio of 35.97.

EV / Earnings 27.11
EV / Sales 6.23
EV / EBITDA 19.71
EV / EBIT 21.20
EV / FCF 35.97

Financial Position

The company has a current ratio of 14.30, with a Debt / Equity ratio of 0.01.

Current Ratio 14.30
Quick Ratio 12.68
Debt / Equity 0.01
Debt / EBITDA 0.04
Debt / FCF 0.07
Interest Coverage 68.72

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 16.28%
Revenue Per Employee 944.47M
Profits Per Employee 217.07M
Employee Count 36
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BIOBIJOU has paid 1.85 billion in taxes.

Income Tax 1.85B
Effective Tax Rate 19.14%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 17,855.40
200-Day Moving Average n/a
Relative Strength Index (RSI) 45.63
Average Volume (20 Days) 141,621

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BIOBIJOU had revenue of KRW 34.00 billion and earned 7.81 billion in profits. Earnings per share was 632.31.

Revenue34.00B
Gross Profit 17.85B
Operating Income 9.99B
Pretax Income 9.66B
Net Income 7.81B
EBITDA 10.75B
EBIT 9.99B
Earnings Per Share (EPS) 632.31
Full Income Statement

Balance Sheet

The company has 34.39 billion in cash and 424.73 million in debt, giving a net cash position of 33.96 billion or 2,257.40 per share.

Cash & Cash Equivalents 34.39B
Total Debt 424.73M
Net Cash 33.96B
Net Cash Per Share 2,257.40
Equity (Book Value) 61.21B
Book Value Per Share 4,068.68
Working Capital 48.79B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.10 billion and capital expenditures -206.18 million, giving a free cash flow of 5.89 billion.

Operating Cash Flow 6.10B
Capital Expenditures -206.18M
Free Cash Flow 5.89B
FCF Per Share 391.55
Full Cash Flow Statement

Margins

Gross margin is 52.50%, with operating and profit margins of 29.39% and 22.98%.

Gross Margin 52.50%
Operating Margin 29.39%
Pretax Margin 28.42%
Profit Margin 22.98%
EBITDA Margin 31.61%
EBIT Margin 29.39%
FCF Margin 17.33%

Dividends & Yields

BIOBIJOU does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 3.18%
FCF Yield 2.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BIOBIJOU has an Altman Z-Score of 44.36 and a Piotroski F-Score of 2.

Altman Z-Score 44.36
Piotroski F-Score 2